LaVoieHealthScience Honored with Silver Bell Ringer Award for Investor/Financial Relations Campaign

Campaign Optimized On-Message Coverage of Pivotal Phase 3 Data

BOSTON, MA – June 14, 2018 – LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, announced today it has won a Silver Bell Ringer Award in the Investor/Financial Relations Campaign category from the Publicity Club of New England for the agency’s work on behalf of its client, Ampio Pharmaceuticals (NYSE MKT: AMPE), a development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options.

LaVoieHealthScience developed an Investor/Financial Relations strategic communications campaign to ensure on-message visibility for Ampio’s announcement of pivotal data for Ampion™ for the treatment of osteoarthritis of the knee.

The campaign included a press release that was offered to reporters on an embargoed basis, as well as a post-distribution follow-on campaign that targeted the full range of national, local, business, trade and orthopedic outlets. In addition to the earned media, the campaign included sponsored print and radio content. An important part of the campaign also included a full suite of “infrastructure” including detailed timelines and Q&A preparation.

“I want to thank our talented team and our client, Ampio for their specialized thinking and spot-on execution on this important investor communications program.  We are honored to be recognized again in 2018 by the Publicity Club of New England,” stated Donna L. LaVoie, President and CEO.

Since 1969, the Publicity Club of New England’s Bell Ringer Awards have been a symbol of outstanding achievement for New England public relations and communications professionals in every field and industry and across all forms of media.

About LaVoieHealthScience

LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations. The agency has received over 30 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients and is ranked among the 2017 Inc. 5000 list of fastest growing private companies for the fourth year. In addition to clients listed above, LaVoieHealthScience represents leaders such as Affimed, BioAxone BioSciences, Biotechnology Innovation Organization, Fusion Pharmaceuticals, Genosco, Landos Biopharma, LEO Science Hub, Life Sciences Corridor, NewLink Genetics, Newron Pharmaceuticals, Origenis GmbH, PathMaker Biosystems, Scioto Biosciences, Symbiotix, Triumvira Immunologics, Xontogeny LLC, XenoTherapeutics and other emerging health and science companies.

###

Media Contact:
Katie Gallagher
Account Manager, PR and Marketing
kgallagher@lavoiehealthscience.com
617-374-8800 x109